(MedPage Today) -- A generic version of the top-selling pain drug pregabalin won FDA approval last week. In other news, a novel drug for multidrug-resistant TB is now under FDA review.
via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment